Trial intelligence / Profile preview

Biology and Experience of Eating in Women With Obesity

NCT02805972Phase 2Completed

Sponsor
University of California, San Francisco
Start
May 2017
Primary completion
Jul 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of naloxone in obesity, sponsored by University of California, San Francisco. Started May 2017; status: completed.

02

Drugs

naloxone
03

Conditions

obesity

Beyond the preview

Go deeper on NCT02805972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02805972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call